Cellebrite DI (CLBT) Net Income towards Common Stockholders (2020 - 2026)

Cellebrite DI has reported Net Income towards Common Stockholders for 7 years, with the latest figure at $6.4 million in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 67.29% year-over-year to $6.4 million in Q2 2026; TTM through Jun 2026 was $58.8 million, a 138.93% increase from a year earlier, with the FY2025 full-year figure at $77.8 million, up 127.5% from the prior year.
• Net Income towards Common Stockholders was $6.4 million for Q2 2026 at Cellebrite DI, down from $10.9 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $55.4 million in Q1 2022, with the low at -$207.1 million in Q3 2024.
• Average Net Income towards Common Stockholders over 5 years is -$8.2 million, with a median of $9.0 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders surged 15246.99% in 2022, then tumbled 3286.05% in 2024.
• Over 5 years, Net Income towards Common Stockholders stood at $7.1 million in 2022, then slumped by 306.94% to -$14.6 million in 2023, then jumped by 231.56% to $19.3 million in 2024, then rose by 10.34% to $21.3 million in 2025, then sank by 70.03% to $6.4 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $6.4 million (Q2 2026), $10.9 million (Q1 2026), and $21.3 million (Q4 2025), per Business Quant data.